Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MET amplification + MET Exon 14 mutation
i
Other names:
DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Associations
(3)
News
Trials
C2 | Sensitive
C4 | Sensitive
C2 | Resistant
C4 | Resistant
Show legend
Drug categories
Tyrosine Kinase Inhibitors
Cancel
Non Small Cell Lung Cancer
Lung Adenocarcinoma
crizotinib
C2
MET amplification + MET Exon 14 mutation
|
Non Small Cell Lung Cancer
|
crizotinib
savolitinib
C4
MET amplification + MET Exon 14 mutation
|
Lung Adenocarcinoma
|
savolitinib
cabozantinib tablet
C4
MET amplification + MET Exon 14 mutation
|
Non Small Cell Lung Cancer
|
cabozantinib tablet
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login